Engineers Gate Manager’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
+56,142
| New | +$1.22M | 0.02% | 1017 |
|
|
2025
Q1 | – | Sell |
-42,737
| Closed | -$892K | – | 2222 |
|
|
2024
Q4 | $892K | Sell |
42,737
-4,159
| -9% | -$86.8K | 0.02% | 1081 |
|
|
2024
Q3 | $932K | Sell |
46,896
-39,652
| -46% | -$788K | 0.02% | 1035 |
|
|
2024
Q2 | $1.34M | Sell |
86,548
-60,407
| -41% | -$936K | 0.03% | 750 |
|
|
2024
Q1 | $2.34M | Buy |
+146,955
| New | +$2.34M | 0.06% | 421 |
|
|
2023
Q4 | – | Sell |
-102,731
| Closed | -$1.2M | – | 2012 |
|
|
2023
Q3 | $1.2M | Buy |
+102,731
| New | +$1.2M | 0.04% | 600 |
|
|
2023
Q2 | – | Sell |
-26,011
| Closed | -$431K | – | 1781 |
|
|
2023
Q1 | $431K | Buy |
+26,011
| New | +$431K | 0.02% | 1052 |
|
|
2022
Q4 | – | Sell |
-38,274
| Closed | -$491K | – | 1724 |
|
|
2022
Q3 | $491K | Sell |
38,274
-21,965
| -36% | -$282K | 0.03% | 822 |
|
|
2022
Q2 | $422K | Buy |
60,239
+18,794
| +45% | +$132K | 0.02% | 1205 |
|
|
2022
Q1 | $344K | Buy |
+41,445
| New | +$344K | 0.01% | 1301 |
|
|
2021
Q4 | – | Sell |
-15,395
| Closed | -$82K | – | 2052 |
|
|
2021
Q3 | $82K | Sell |
15,395
-30,708
| -67% | -$164K | ﹤0.01% | 1553 |
|
|
2021
Q2 | $265K | Sell |
46,103
-9,963
| -18% | -$57.3K | 0.02% | 1218 |
|
|
2021
Q1 | $258K | Buy |
56,066
+42,870
| +325% | +$197K | 0.01% | 1418 |
|
|
2020
Q4 | $44K | Sell |
13,196
-208,162
| -94% | -$694K | ﹤0.01% | 1640 |
|
|
2020
Q3 | $657K | Buy |
+221,358
| New | +$657K | 0.03% | 842 |
|
|
2015
Q2 | – | Sell |
-14,882
| Closed | -$64K | – | 1044 |
|
|
2015
Q1 | $64K | Buy |
+14,882
| New | +$64K | 0.01% | 902 |
|